Christophe Van Vaeck
Principal
Business and Management
Gimv
Belgium
Biography
Christophe Van Vaeck earned his PhD in Biology at the lab of Molecular and Cellular Biology at the University of Leuven (KU Leuven) in 2000. He then switched to the financial world and worked as a financial analyst Life Sciences at KBC Securities, where he guided the Euronext IPOs of Galapagos, deVGen, Thrombogenics and Ablynx. In 2008, he joined Gimv as senior investment manager. Christophe is a board member at Almaviva, Multiplicom and AgroSavfe and is actively involved in the Gimv-Agri+ Investment Fund.
Research Interest
Business and Management
